News Focus
News Focus
icon url

Gator328

12/27/17 1:58 PM

#135371 RE: anders2211 #135369

If that's all it is, just giving the highest dose possible, why not start the trial immediately? Clearly Anavex wants more data because that alone is not sufficient to go ahead full speed. There could be lots of other factors other than dosage that makes one group respond more than another.

I do agree that the best way to play this is to invest, and hold, for at least two years.
icon url

Investor2014

12/27/17 2:07 PM

#135373 RE: anders2211 #135369

Don’t forget the puzzling outliers. One on low blood concentration doing well another on high concentration not so much.

It is not completely straightforward. One hopes the gene and gut profiling holds the clues. This is taking time to figure out or to procrastinate over if no clear explanation emerge.
icon url

powerwalker

12/27/17 2:36 PM

#135384 RE: anders2211 #135369

anders, the one thing that was common to all 6 is that each is DPZ naive as they were called in first report at six months.